MWS
ABBV icon

MFA Wealth Services’s AbbVie ABBV Stock Holding History

MFA Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$856K Buy
3,401
+358
+12% +$77K 0.51% 54
2026
Q1 		$662K Buy
3,043
+143
+5% +$31.7K 0.44% 64
2025
Q4 		$663K Buy
2,900
+290
+11% +$66.1K 0.45% 60
2025
Q3 		$604K Buy
2,610
+100
+4% +$20.4K 0.42% 66
2025
Q2 		$466K Buy
2,510
+41
+2% +$7.62K 0.35% 69
2025
Q1 		$517K Buy
2,469
+105
+4% +$20.4K 0.43% 56
2024
Q4 		$420K Buy
+2,364
New +$435K 0.34% 70

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

MFA Wealth Services's ABBV Position: Q2 2026 in Review

MFA Wealth Services increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $77K and bringing the position to 3,401 shares worth $856K. The position accounts for 0.51% of the portfolio, ranked #54.

MFA Wealth Services first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MFA Wealth Services held 3,401 shares of AbbVie worth $856K as of Q2 2026.
  • MFA Wealth Services bought 358 AbbVie shares in Q2 2026, an estimated $77K.
  • AbbVie made up 0.51% of MFA Wealth Services's portfolio in Q2 2026, its #54 holding.
  • MFA Wealth Services first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MFA Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.